Immix Biopharma, Inc.IMMXNASDAQ
Loading
Asset Growth Under PressureDecelerating
Percentile Rank60
3Y CAGR-83.3%
Studio
Year-over-Year Change

Year-over-year total asset growth rate

3Y CAGR
-83.3%/yr
Annual compound
Percentile
P60
Within normal range
vs 3Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
202415.17%
202333.65%
2022-18.05%
20213271.42%
2020-42.78%
20190.00%